
Cure51revenue
Paris, FranceFounded 2021CEO Nicolas Wolikow
Cure51 is a Paris-based Techbio company on a mission to decode the biology of exceptional cancer patients - the Outliers - who survive aggressive cancers against all odds.
Cure51 revenue
Cure51 has not published its revenue. Growjo puts it at about $9.5M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $9.5MEST | Growjo estimate |
Cure51 CEO & employees
Nicolas Wolikow is CEO of Cure51. Cure51 has 52 employees (September 2025, LinkedIn).
Cure51 FAQ
What is Cure51's revenue?
Growjo estimates Cure51's revenue at about $9.5M a year (September 2025). The company hasn't published its own figure.
How many employees does Cure51 have?
Cure51 has 52 employees as of September 2025, according to LinkedIn.
Who is the CEO of Cure51?
Nicolas Wolikow is the CEO of Cure51.
Categories
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Cure51? Join the podcast